Cellectis (CLLS) Long-Term Deferred Tax (2024 - 2026)

Cellectis (CLLS) recorded quarterly Long-Term Deferred Tax of $382000.0 in Q1 2026, little changed quarter-over-quarter from $382000.0 in Q4 2025, and little changed on a YoY basis from $382000.0 in Q1 2025.

Cellectis (CLLS) Long-Term Deferred Tax (2024 - 2026) Analysis & Trends

Cellectis' Long-Term Deferred Tax history runs 3 years deep, the most recent figure standing at $382000.0 for Q1 2026.

  • In Q1 2026, Long-Term Deferred Tax changed 0.0% year-over-year to $382000.0; the TTM figure through Mar 2026 stood at $382000.0 (changed 0.0% YoY), while the FY2025 annual figure was $382000.0, changed 0.0% from the prior year.
  • Long-Term Deferred Tax was $382000.0 for Q1 2026 at Cellectis, roughly flat from $382000.0 in the prior quarter.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $803000.0 in Q3 2024 to a low of $382000.0 in Q4 2024.
  • Historically, Long-Term Deferred Tax has averaged $442142.9 across 3 years, with a median of $382000.0 in 2024.
  • Biggest YoY gain for Long-Term Deferred Tax was 0.0% in 2025; the steepest drop was 52.43% in 2025.
  • A 3-year view of Long-Term Deferred Tax shows it stood at $382000.0 in 2024, then changed by 0.0% to $382000.0 in 2025, then changed by 0.0% to $382000.0 in 2026.
  • The last three Long-Term Deferred Tax figures came in at $382000.0 (Q1 2026), $382000.0 (Q4 2025), and $382000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Cellectis 17.40 Bn 17.21 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 382,000.00
Dec 31, 2025 382,000.00
Sep 30, 2025 382,000.00
Jun 30, 2025 382,000.00
Mar 31, 2025 382,000.00
Dec 31, 2024 382,000.00
Sep 30, 2024 803,000.00